Gastrointestinal manifestations after Roux-en-Y gastric bypass surgery in individuals with and without type 2 diabetes

نویسندگان

چکیده

Background Roux-en-Y gastric bypass (RYGB) surgery is an effective treatment for obesity, which improves cardiovascular health and reduces the risk of premature mortality. However, some reports have suggested that RYGB may predispose patients to adverse outcomes, such as inflammatory bowel disease (IBD) colorectal cancer. Objectives The present prospective study aimed evaluate impact on factors gastrointestinal inflammation in individuals with without type 2 diabetes (T2D). Setting University hospital setting Finland. Methods Blood fecal samples were collected at baseline 6 months after from 30 individuals, 16 had T2D 14 nondiabetics. There also single visits healthy reference patients. Changes factors, serum cholesterol, triglycerides investigated before surgery. Fecal analyzed calprotectin, anti-Saccharomyces cerevisiae immunoglobulin A antibodies (ASCA), active lipopolysaccharide (LPS) concentration, short-chain fatty acids (SCFAs), intestinal alkaline phosphatase activity, methylglyoxal-hydro-imidazolone (MG-H1) protein adducts formation. Results After RYGB, weight decreased average ?21.6% (?27.2 ± 7.8 kg), excess loss averaged 51%, there improvements factors. calprotectin levels (P < .001), LPS concentration .002), ASCA .02), MG-H1 .02) values increased significantly, whereas SCFAs, especially acetate .002) butyrate .03) levels, significantly lowered. Conclusion homeostasis altered several markers suggesting inflammation; however, clinical significance detected changes currently uncertain. As chronic effects, our findings relevance association between risks incident IBD

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Alterations in gastrointestinal physiology after Roux-en-Y gastric bypass.

m h a r orbid obesity is increasing exponentially in the US. pproximately 33.3% of Americans were obese in 1991, ersus 25.4% in 1976. Currently, 54.5% of Americans re overweight, with a body mass index 25. Diet and xercise are implemented initially, they usually fail after years. In response to this epidemic, surgical therapies or morbid obesity have evolved. There are several diferent weight l...

متن کامل

Achalasia after bariatric Roux-en-Y gastric bypass surgery reversal

Achalasia is a rare esophageal motility disorder that is characterized by a loss of peristalsis in the distal esophagus and failure of lower esophageal sphincter relaxation. The risk of developing esophageal motility disorders, including achalasia, following bariatric surgery is controversial and differs based on the type of surgery. Most of the reported cases occurred with laparoscopic adjusta...

متن کامل

Alterations in Gastrointestinal, Endocrine, and Metabolic Processes After Bariatric Roux-en-Y Gastric Bypass Surgery

OBJECTIVE Obesity leads to severe long-term complications and reduced life expectancy. Roux-en-Y gastric bypass (RYGB) surgery induces excessive and continuous weight loss in (morbid) obesity, although it causes several abnormal anatomical and physiological conditions. RESEARCH DESIGN AND METHODS To distinctively unveil effects of RYGB surgery on β-cell function and glucose turnover in skelet...

متن کامل

Successful endoscopic management of gastrointestinal leakages after laparoscopic Roux-en-Y gastric bypass surgery.

BACKGROUND Management of leakages of the gastrojejunal anastomosis after laparoscopic Roux-en-Y gastric bypass (LRYGB) can be complex. New endoscopic techniques such as covered stents and over-the-scope clips (OTCs) have been developed and are valuable alternative therapeutic options to reoperation and drainage. The aim of this study was to compare the value of stents and OTCs with surgical tre...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Surgery for Obesity and Related Diseases

سال: 2021

ISSN: ['1878-7533', '1550-7289']

DOI: https://doi.org/10.1016/j.soard.2020.10.021